Ophthalmology · San Francisco, CA
NPI
1841338845
Since 2007
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2200 Ofarrell St
San Francisco, CA, 94115
Phone (415) 833-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,044
45 services
Medicare patients, 2024
21
Average age 69
Drug cost, 2024
$26K
419 prescriptions
Company payments, 2024
$122
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sid Borirak was code 99213 (office e&m - established), 23 times for 13 patients. In total Sid Borirak billed 45 services in 13 codes, and Medicare paid $5,044.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 23 | 13 | $43.10 | $991 |
By year: 2022 $14K for 69 services; 2023 $4,735 for 37 services; 2024 $5,044 for 45 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sid Borirak prescribed most often to Medicare patients was Latanoprost, with 99 prescriptions and refills. In total Sid Borirak wrote 419 Medicare prescriptions that cost $26K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 99 | 291 | 52 | $1,386 |
| Prednisolone Acetate Generic | 64 | 95 | 48 | $3,486 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 54 | 176 | 36 | $1,081 |
| Brimonidine Tartrate Generic | 31 | 98 | 21 | $434 |
| Polymyxin B Sul-Trimethoprim Polymyxin B Sulf/Trimethoprim | 27 | 28 | 24 | $328 |
| Nevanac Nepafenac | 17 | 17 | Under 11 | $13K |
| Fluorometholone Generic | 15 | 22 | Under 11 | $2,907 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 13 | 13 | 12 | $177 |
| Erythromycin Erythromycin Base | 12 | 12 | Under 11 | $199 |
Brand drugs: 87 claims; generic drugs: 332 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Sid Borirak $122 ($122 in general payments such as food, travel and fees) from 1 company. The largest payer was Genentech USA, Inc. with $122.
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. ROG.SW | 1 | $122 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.